Evidence map›Paper›PMID 26092487›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Reply to Planche et al.

Krishna Rao, Vincent B Young, David M Aronoff

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Krishna RaoDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Veterans Affairs Ann Arbor Healthcare System.
Vincent B YoungDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Department of Microbiology and Immunology, University of Michigan, Ann Arbor.
David M AronoffDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Funding

Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Research Education CoreP30AG024824 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Neil Alexander · 2004 to 2026
$29.2M
The Interplay Between Host Immunity and Clostridium difficile PathogenesisU19AI090871 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YOUNG, VINCENT B · 2010 to 2014
$7.5M
Phylogenomic epidemiology of Clostridium difficileK01AI097281 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WALK, SETH T · 2012 to 2016
$509k
NCATS NIH HHS 2UL1TR000433NCATS NIH HHS UL1 TR000433NIAID NIH HHS K01 AI097281NIAID NIH HHS K01-AI097281NIAID NIH HHS U19 AI090871NIAID NIH HHS U19-AI090871NIA NIH HHS P30 AG024824
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RibotypingBotulinum ToxinsClostridioides difficileEnterocolitis, PseudomembranousFecesFemaleHumansMaleBotulinum Toxins

Identifiers

PMID26092487
PMCPMC4560910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.